Brian Finck

Professor

Washington University in St. Louis

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Brian Finck is a Professor at Washington University in Saint Louis, USA. His research focuses on metabolic diseases, particularly the roles of mitochondrial pyruvate carriers and related therapeutic strategies. He has published extensively on topics such as hepatic mitochondrial function, lipid metabolism, and the treatment of conditions like NAFLD and type 2 diabetes mellitus.

Articles (10)

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (9)

Kevin Cho

Washington University in St. Louis

UNITED STATES

View details

Kyle McCommis

Assistant Professor

Saint Louis University

UNITED STATES

View details

Mihoko Yoshino

Project Professor

Keio University

JAPAN

View details

Timothy Koves

Duke University

UNITED STATES

View details

Rita Brookheart

Assistant Professor

Washington University in St. Louis

UNITED STATES

View details

Bahaa Elgendy

Associate Professor

UNITED STATES

View details

Felicia Allard

Associate Professor

University of Arkansas for Medical Sciences

UNITED STATES

View details

Eric Yee

Associate Professor

University of Arkansas for Medical Sciences

UNITED STATES

View details

Matthew Woolard

Assistant Professor

Louisiana State University Health Sciences Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Brian Finck

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

The Hepatic Mitochondrial Pyruvate Carrier as a Regulator of Systemic Metabolism and a Therapeutic Target for Treating Metabolic Disease

Identification of Novel Mitochondrial Pyruvate Carrier Inhibitors by Homology Modeling and Pharmacophore-Based Virtual Screening

Mitochondrial pyruvate carrier inhibitors improve metabolic parameters in diet-induced obese mice.

Recent Advances in the Medicinal Chemistry of Farnesoid X Receptor.

Exogenous phosphatidic acid reduces acetaminophen-induced liver injury in mice by activating hepatic interleukin-6 signaling through inter-organ crosstalk.

Myeloid-associated lipin-1 transcriptional co-regulatory activity is atheroprotective.

Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus.

Myocardial Lipin 1 knockout in mice approximates cardiac effects of human LPIN1 mutations.

Importance of Adipose Tissue NAD+ Biology in Regulating Metabolic Flexibility.

Multiple antisense oligonucleotides targeted against monoacylglycerol acyltransferase 1 (Mogat1) improve glucose metabolism independently of Mogat1.

Collaborators (9)

Kevin Cho

Kyle McCommis

Mihoko Yoshino

Timothy Koves

Rita Brookheart

Bahaa Elgendy

Felicia Allard

Eric Yee

Matthew Woolard

Make your next move.